NCT03761225
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03761225
Title Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Recruitment Completed
Gender male
Phase Phase III
Variant Requirements No
Sponsors AB Science
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | FRA | CAN

Facility Status City State Zip Country Details
Centre Hospitalier Universitaire de Sherbrooke Sherbrooke 13001 Canada Details
Polyclinique d'oncologie de Gentilly Nancy 54100 France Details
Sanjay Gandhi Post Graduate Institute of Medical Sciences Lucknow 226014 India Details
Centro di Riferimento Oncologico Aviano 33081 Italy Details
Istituto Europeo di Oncologia Milan 20141 Italy Details
Azienda Ospedaliero Universitaria Pisana Pisa 56100 Italy Details
Universiti Malaya Medical Centre Kuala Lumpur 59100 Malaysia Details
Clinical Oncology Dispensary Omsk 644013 Russia Details
Clinic Andros LLC Saint Petersburg 197136 Russia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field